Symrise AG (SY1):企業の財務・戦略的SWOT分析

◆英語タイトル:Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDING33326FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Ingredients
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥53,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Symrise AG (SY1) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Symrise AG (Symrise) is a provider of flavors and fragrances. The company develops, produces, and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions. It provides biofunctional and bioactive ingredients and substances to the health and personal care sector. The company develops products from natural raw materials like vanilla, citrus fruits, onions, fish, meat, blossoms, and plant materials. Symrise serves perfume, cosmetics, food, pharma and nutritional supplements industries, and manufacturers of household products. The company has operational presence in the Europe, Africa, the Middle East, Asia Pacific, North America, and Latin America. Symrise is headquartered in Holzminden, Niedersachsen, Germany.

Symrise AG Key Recent Developments

Jul 24,2020: Symrise inaugurates L’appartement Étoile
Jun 18,2020: Michael König elected Chairman of the Supervisory Board of Symrise AG
May 26,2020: Three Symrise products win first prize at BSB Innovation Awards 2020
Mar 10,2020: Symrise successfully continues profitable growth
Mar 02,2020: Symrise receives international “A” rating from CDP for outstanding environmental protection

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Symrise AG – Key Facts
Symrise AG – Key Employees
Symrise AG – Key Employee Biographies
Symrise AG – Major Products and Services
Symrise AG – History
Symrise AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Symrise AG – Business Description
Business Segment: Flavor
Overview
Performance
Key Stats
Business Segment: Nutrition
Overview
Performance
Key Stats
Business Segment: Scent & Care
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Target Markets
Performance
Geographical Segment: EAME
Target Markets
Performance
Geographical Segment: Latin America
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
R&D Overview
Symrise AG – Corporate Strategy
Symrise AG – SWOT Analysis
SWOT Analysis – Overview
Symrise AG – Strengths
Symrise AG – Weaknesses
Symrise AG – Opportunities
Symrise AG – Threats
Symrise AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Symrise AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jul 24, 2020: Symrise inaugurates L’appartement Étoile
Jun 18, 2020: Michael König elected Chairman of the Supervisory Board of Symrise AG
May 26, 2020: Three Symrise products win first prize at BSB Innovation Awards 2020
Mar 10, 2020: Symrise successfully continues profitable growth
Mar 02, 2020: Symrise receives international “A” rating from CDP for outstanding environmental protection
Jan 20, 2020: Symrise receives top score of A in international climate protection rating
Jan 20, 2020: Michael König appointed to Symrise Supervisory Board
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Symrise AG, Key Facts
Symrise AG, Key Employees
Symrise AG, Key Employee Biographies
Symrise AG, Major Products and Services
Symrise AG, History
Symrise AG, Subsidiaries
Symrise AG, Key Competitors
Symrise AG, Ratios based on current share price
Symrise AG, Annual Ratios
Symrise AG, Annual Ratios (Cont...1)
Symrise AG, Annual Ratios (Cont...2)
Symrise AG, Interim Ratios
Symrise AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Symrise AG (SY1):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Silmag SA:企業の製品パイプライン分析2018
    Summary Silmag SA (Silmag) is a manufacturer of biomedical products. The company offers products for vascular access, drainage, digestive tract, airway and urinary system. Its products include catheters, drainage tube, occlusion and identification tape, airway tube, double pigtail ureteral stent, cl …
  • Sygnity SA (SGN):企業の財務・戦略的SWOT分析
    Sygnity SA (SGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Toyota Industries Corporation:企業の戦略・SWOT・財務分析
    Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Tadano Ltd:企業の戦略・SWOT・財務分析
    Tadano Ltd - Strategy, SWOT and Corporate Finance Report Summary Tadano Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Quest Diagnostics Incorporated:戦略・SWOT・企業財務分析
    Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析
    MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Saline Water Conversion Corp:企業の発電所・SWOT分析2018
    Saline Water Conversion Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Qualcomm Incorporated (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Incorporated (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sequana Medical AG-医療機器分野:企業M&A・提携分析
    Summary Sequana Medical AG (Sequana Medical), formerly NovaShunt AG is a medical device company that develops, manufactures and commercializes automated implantable pump systems to monitor fluid balance within the body. The company provides solution to manage ascites, which can occur as a symptom of …
  • ADC Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary ADC Therapeutics SA (ADCT) is a pharmaceutical company that develops a pipeline of proprietary antibody drug conjugates for the treatment of both solid and hematological cancers. The company offers combining monoclonal antibodies specific to particular types of tumor cells with a novel class …
  • Brick Brewing Co. Limited:企業の戦略・SWOT・財務分析
    Brick Brewing Co. Limited - Strategy, SWOT and Corporate Finance Report Summary Brick Brewing Co. Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Veikkaus Oy:企業の戦略的SWOT分析
    Veikkaus Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ultragenyx Pharmaceutical Inc (RARE):企業の財務・戦略的SWOT分析
    Ultragenyx Pharmaceutical Inc (RARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • Atriva Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Atriva Therapeutics GmbH (Atriva Therapeutics) is a developer of antiviral therapies that develops therapies against seasonal and pandemic influenza. The company develops ATR-001 drug candidate, a MEK inhibitor which targets influenza. It also offers repurposing existing MEK inhibitors, orig …
  • CompuGroup Medical SE:企業のM&A・事業提携・投資動向
    CompuGroup Medical SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CompuGroup Medical SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Acorda Therapeutics Inc (ACOR)-製薬・医療分野:企業M&A・提携分析
    Summary Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. The company’s commercial products include Ampyra (dalfampridine), a treatment to improve walking in patients with multiple …
  • Juwi Inc:電力:M&Aディール及び事業提携情報
    Summary Juwi Inc (Juwi), a subsidiary of juwi AG is a renewable energy company that operates wind and solar projects. The company’s services include development and acquisition, engineering, procurement, construction and operations and maintenance. Juwi's operations and maintenance services comprise …
  • Whiting Petroleum Corp (WLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Whiting Petroleum Corp (Whiting Petroleum) is an independent oil and gas company that develops, produces, acquires and explores crude oil, natural gas and natural gas liquids (NGL) in the Rocky Mountains region of the US. The company has oil and gas properties in Northern Rocky Mountains whi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆